Novozymes reported 244.9M in Selling and Administration Expenses for its fiscal quarter ending in March of 2026.





Selling And Administration Expenses Change Date
Arq USD 4.75M 1.76M Mar/2026
Avient USD 189.2M 6M Sep/2026
Chemours USD -25M 494M Sep/2026
Coronado Global Resources USD 90.35M 1.18M Mar/2026
Corteva USD 1.16B 287M Jun/2026
Metallus USD 22.3M 2.2M Dec/2025
Newmont Corporation USD 82M 3M Sep/2026
Novozymes 244.9M 4.8M Mar/2026
SSR Mining USD 35.59M 7.94M Sep/2026